2
Clinical Trials associated with Darbepoetin alfa (Zydus Cadila Healthcare Ltd.)A randomized, open label, multi-center study to evaluate the efficacy, tolerability and safety of Darbepoetin alfa as compared to Erythropoietin in anemia associated with chronic kidney disease (CKD)
An open label phase 2 study of doxorubicin and cyclophosphamide followed by paclitaxel (AC-T) delivered every 14 days with pegfilgrastim and darbepoetin alfa support for the adjuvant treatment of women with breast cancer
100 Clinical Results associated with Darbepoetin alfa (Zydus Cadila Healthcare Ltd.)
100 Translational Medicine associated with Darbepoetin alfa (Zydus Cadila Healthcare Ltd.)
100 Patents (Medical) associated with Darbepoetin alfa (Zydus Cadila Healthcare Ltd.)
100 Deals associated with Darbepoetin alfa (Zydus Cadila Healthcare Ltd.)